Development of a gene transfer-based treatment for radiation-induced salivary hypofunction

Oral Oncology

Volumn 46, Issue 1, 2010, Pages 4-8

  Baum, Bruce J ^a   Zheng, Changyu ^a   Alevizos, Ilias ^a   Cotrim, Ana P ^a   Liu, Shuying ^a   McCullagh, Linda ^a   Goldsmith, Corinne M ^a   McDermott, Nancy ^a   Chiorini, John A ^a   Nikolov, Nikolay P ^a   Illei, Gabor G ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Adenovirus; Aquaporin 1; Gene therapy; Oral cancer; Radiation; Xerostomia

Indexed keywords

ADENOVIRUS VECTOR; AQUAPORIN 1; COMPLEMENTARY DNA;

CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GENE TRANSFER; HUMAN; IN VIVO STUDY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SALIVARY GLAND DISEASE; SALIVARY HYPOFUNCTION; VIRAL GENE DELIVERY SYSTEM;

AQUAPORIN 1; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; MALE; RADIATION INJURIES; XEROSTOMIA;

EID: 72149106158     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.09.004     Document Type: Review

References (38)

1. Jamal A., Siegel R., Ward E., Hao Y., Xu J., and Thun M.J. Cancer statistics 2009. CA Cancer J Clin 59 (2009) 225-249
2. Vissink A., Jansma J., Spijkervet F.K.L., Burlage F.R., and Coppes R.P. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14 (2003) 199-212
3. Vissink A., Burlage F.R., Spijkervet F.K.L., Jansma J., and Coppes R.P. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med 14 (2003) 213-225
4. Langendijk J.A., Doornaert P., Verdonck-de Leeuw I.M., Leemans C.R., Aaronson N.K., and Slotman B.J. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 26 (2008) 3770-3776
5. Ho K.F., Farnell D.J.J., Routledge J.A., Burns M.P., Sykes A.J., Slevin N.J., et al. Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapy. Eur J Cancer 45 (2009) 1992-1998
6. Teguh D.N., Levendag P.C., Noever I., Voet P., van der Est H., van Roou P., et al. Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer. Int J Radiat Oncol Biol Phys (2009) 10.1016/j.irobp.2008.11.05
7. Brizel D.M., and Overgaard J. Does amifostine have a role in chemoradiation treatment?. Lancet Oncol 4 (2003) 378-381
8. Jha N., Seikaly H., Harris J., Williamd D., Sultanem K., Hier M., et al. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia. Head Neck 31 (2009) 234-243
9. Chen W.-C., Hwang T.-Z., Wang W.-H., Lu C.-H., Chen C.-C., Chen C.-M., et al. Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity. Oral Oncol 45 (2009) 505-510
10. Vergeer M.R., Doornaert P., Reitvelt D.H.F., Leemans C.R., Slotman B.J., and Langendijk J.A. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a non-randomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys 74 (2009) 1-8
11. Lee N., Harris J., Garden A.S., Straube W., Glisson B., Xia P., et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation Therapy Oncology Group phase III trial 0225. J Clin Oncol (2009) 10.1200/JCO.2008.19.910
12. Cox J.D., Steitz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for research and treatment of cancer. Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
13. Baum B.J., Zheng C., Cotrim A.P., McCullagh L., Goldsmith C.M., Brahim J.S., et al. Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction. In: Beitz E. (Ed). Aquaporins. Handbook of experimental pharmacology vol. 190 (2009), Springer, Berlin, Heidelberg 403-418
14. Preston G.M., and Agre P. Isolation of the cDNA for erythrocyte integral membrane protein of 28 kilodaltons: member of an ancient channel family. Proc Natl Acad Sci USA 88 (1991) 11110-11114
15. Delporte C., O'Connell B.C., He X., Lancaster H.E., O'Connell A.C., Agre P., et al. Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc Natl Acad Sci USA 94 (1997) 3268-3273
16. Baum B.J. Principles of saliva secretion. Ann NY Acad Sci 694 (1993) 17-23
17. Vitolo J.M., and Baum B.J. The use of gene transfer for the protection and repair of salivary glands. Oral Dis 8 (2002) 183-191
18. Cherry C.P., and Glucksman A. Injury and repair following irradiation of salivary glands in male rats. Brit J Radiol 32 (1959) 596-608
19. Abok K., Brunck U., Jung B., and Ericsson J. Morphologic and histochemical studies of the differing radiosensitivity of ductular and acinar cells of the rat submandibular gland. Virchows Arch B 45 (1984) 443-460
20. Casals M., and Haskins M. Large animal models and gene therapy. Eur J Hum Genet 14 (2006) 266-272
21. O'Connell A.C., Baccaglini L., Fox P.C., O'Connell B.C., Kenshalo D., Oweisy H., et al. Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates. Cancer Gene Ther 6 (1999) 505-513
22. Li J., Shan Z., Ou G., Liu X., Zhang C., Baum B.J., et al. Structural and functional characteristics of irradiation damage to parotid glands in the miniature pig. Int J Radiat Oncol Biol Phys 62 (2005) 1510-1516
23. Shan Z., Li J., Zheng C., Liu X., Fan Z., Zhang C., et al. Increased fluid secretion after adenoviral-mediated transfer of the human aquaporin-1 cDNA to irradiated miniature pig parotid glands. Mol Ther 11 (2005) 444-451
24. Zheng C., Goldsmith C.M., Mineshiba F., Chiorini J.A., Kerr A., Wenk M.L., et al. Toxicity and biodistribution of a first-generation recombinant adenoviral vector, encoding aquaporin-1, after retroductal delivery to a single rat submandibular gland. Hum Gene Ther 17 (2006) 1122-1133
25. Fox P.C., Busch K.A., and Baum B.J. Subjective reports of xerostomia and objective measures of gland performance. J Am Dent Assoc 115 (1987) 581-584
26. Pai S., Ghezzi E.M., and Ship J.A. Development of a visual analogue scale questionnaire for subjective assessment of salivary dysfunction. Oral Surg 91 (2001) 311-316
27. Baum B.J., Wellner R.B., and Zheng C. Gene transfer to salivary glands. Int Rev Cytol 213 (2002) 93-146
28. Kagami H., Atkinson J.C., Michalek S.M., Handelman B., Yu S., Baum B.J., et al. Repetitive adenovirus administration to the parotid gland: role of immunological barriers and induction of oral tolerance. Hum Gene Ther 9 (1998) 305-313
29. Braddon V.R., Chiorini J.A., Wang S., Kotin R.M., and Baum B.J. Adenoassociated virus-mediated transfer of a functional water channel into salivary epithelial cells in vitro and in vivo. Hum Gene Ther 9 (1998) 2777-2785
30. Voutetakis A., Kok M.R., Zheng C., Bossis I., Wang J., Cotrim A.P., et al. Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics. Proc Natl Acad Sci USA 101 (2004) 3053-3058
31. Voutetakis A., Zheng C., Mineshiba F., Cotrim A.P., Goldsmith C.M., Schmidt M., et al. Adeno-associated virus serotype 2-mediated gene transfer to the parotid glands of nonhuman primates. Hum Gene Ther 18 (2007) 142-150
32. Li J., Zheng C., Zhang X., Liu X., Zhang C., Goldsmith C.M., et al. Developing a convenient large animal model for gene transfer to salivary glands in vivo. J Gene Med 6 (2004) 55-63
33. Harvey B.G., Maroni J., O'Donoghue K.A., Chu K.W., Muscat J.C., Pippo A.L., et al. Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum Gene Ther 13 (2002) 15-63
34. Crystal R.G., Harvey B.G., Wisnivesky J.P., O'Donoghue K.A., Chu K.W., Maroni J., et al. Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum Gene Ther 13 (2002) 65-100
35. Raper S.E., Chirmule N., Lee F.S., Wivel N.A., Bagg A., Gao G.P., et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80 (2003) 148-158
36. Baum B.J., Voutetakis A., and Wang J. Salivary glands: novel target sites for gene therapeutics. Trends Mol Med 10 (2004) 585-590
37. Baum B.J., Zheng C., Cotrim A.P., Goldsmith C.M., Atkinson J.C., Brahim J.S., et al. Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction. Biochim Biophys Acta 1758 (2006) 1071-1077
38. Delporte C.D., Hoque A.T.M., Kulakusky J.A., Braddon V.R., Goldsmith C.M., Wellner R.B., et al. Relationship between adenovirus-mediated aquaporin-1 expression and fluid movement across epithelial cells. Biochem Biophys Res Commun 246 (1998) 584-588